ID   HBG1_HUMAN              Reviewed;         147 AA.
AC   P69891; P02096; P62027; Q549G1; Q8TDA1; Q96FH7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   07-APR-2021, entry version 173.
DE   RecName: Full=Hemoglobin subunit gamma-1;
DE   AltName: Full=Gamma-1-globin;
DE   AltName: Full=Hb F Agamma;
DE   AltName: Full=Hemoglobin gamma-1 chain;
DE   AltName: Full=Hemoglobin gamma-A chain;
GN   Name=HBG1; ORFNames=PRO2979;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7438203; DOI=10.1016/0092-8674(80)90426-2;
RA   Slightom J.L., Blechl A.E., Smithies O.;
RT   "Human fetal G gamma- and A gamma-globin genes: complete nucleotide
RT   sequences suggest that DNA can be exchanged between these duplicated
RT   genes.";
RL   Cell 21:627-638(1980).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7332928; DOI=10.1016/0092-8674(81)90302-0;
RA   Shen S., Slightom J.L., Smithies O.;
RT   "A history of the human fetal globin gene duplication.";
RL   Cell 26:191-203(1981).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Bi J., Zhou G., Dong C., Zai Y., Xu W.,
RA   Gao F., Liu M., He F.;
RT   "Functional prediction of the coding sequences of 75 new genes deduced by
RT   analysis of cDNA clones from human fetal liver.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-76.
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-30.
RA   Seelig H.-P., Vogel M., Wiemann C., Renz M.;
RT   "Homo sapiens HBG1 gene with a 4 bp deletion upstream of the promoter
RT   region.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PROTEIN SEQUENCE OF 2-60; 67-77 AND 84-145, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   MODIFICATION AT LEU-142.
RX   PubMed=7690768; DOI=10.1016/0378-4347(93)80418-4;
RA   Wilson J.B., Brennan S.O., Allen J., Shaw J.G., Gu L.H., Huisman T.H.;
RT   "The M gamma chain of human fetal hemoglobin is an A gamma chain with an in
RT   vitro modification of gamma 141 leucine to hydroxyleucine.";
RL   J. Chromatogr. A 617:37-42(1993).
RN   [9]
RP   INDUCTION.
RX   PubMed=16131492; DOI=10.1074/jbc.m504402200;
RA   Blau C.A., Barbas C.F., Bomhoff A.L., Neades R., Yan J., Navas P.A.,
RA   Peterson K.R.;
RT   "{gamma}-Globin gene expression in chemical inducer of dimerization (CID)-
RT   dependent multipotential cells established from human {beta}-globin locus
RT   yeast artificial chromosome ({beta}-YAC) transgenic mice.";
RL   J. Biol. Chem. 280:36642-36647(2005).
RN   [10]
RP   SUBUNIT, AND DEVELOPMENTAL STAGE.
RX   PubMed=20925047; DOI=10.1002/pd.2619;
RA   Li T.K., Leung K.Y., Lam Y.H., Tang M.H., Chan V.;
RT   "Haemoglobin level, proportion of haemoglobin Bart's and haemoglobin
RT   Portland in fetuses affected by homozygous alpha0-thalassemia from 12 to 40
RT   weeks' gestation.";
RL   Prenat. Diagn. 30:1126-1130(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   SUBUNIT, AND DEVELOPMENTAL STAGE.
RX   PubMed=21747884; DOI=10.5045/kjh.2011.46.2.118;
RA   Olufemi A.E., Sola O.B., Oluwaseyi B.E., Ajani R.A., Olusoji M.O.,
RA   Olubunmi H.R.;
RT   "Hemoglobin F level in different hemoglobin variants.";
RL   Korean J. Hematol. 46:118-122(2011).
RN   [13]
RP   SUBUNIT, AND DEVELOPMENTAL STAGE.
RX   PubMed=22096240; DOI=10.1182/blood-2011-09-382408;
RA   Musallam K.M., Sankaran V.G., Cappellini M.D., Duca L., Nathan D.G.,
RA   Taher A.T.;
RT   "Fetal hemoglobin levels and morbidity in untransfused patients with beta-
RT   thalassemia intermedia.";
RL   Blood 119:364-367(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-51; SER-53 AND
RP   SER-140, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 2-147 IN COMPLEX WITH HEME,
RP   SUBUNIT, AND HOMOTETRAMER.
RX   PubMed=11514664; DOI=10.1110/ps.11701;
RA   Kidd R.D., Baker H.M., Mathews A.J., Brittain T., Baker E.N.;
RT   "Oligomerization and ligand binding in a homotetrameric hemoglobin: two
RT   high-resolution crystal structures of hemoglobin Bart's (gamma(4)), a
RT   marker for alpha-thalassemia.";
RL   Protein Sci. 10:1739-1749(2001).
RN   [16]
RP   ACETYLATION AT GLY-2.
RX   PubMed=5554303;
RA   Stegink L.D., Meyer P.D., Brummel M.C.;
RT   "Human fetal hemoglobin F 1. Acetylation status.";
RL   J. Biol. Chem. 246:3001-3007(1971).
RN   [17]
RP   VARIANT BASKENT THR-129.
RX   PubMed=2454900; DOI=10.3109/03630268808996888;
RA   Altay C., Gurgey A., Wilson J.B., Hu H., Webber B.B., Kutlar F.,
RA   Huisman T.H.J.;
RT   "Hb F-Baskent or alpha 2A gamma 128(H6)Ala-->Thr.";
RL   Hemoglobin 12:87-89(1988).
RN   [18]
RP   VARIANT BEECH ISLAND ASP-54.
RX   PubMed=2417989; DOI=10.3109/03630268508997032;
RA   Chen S.S., Wilson J.B., Webber B.B., Huisman T.H.J.;
RT   "Hb F-Beech Island or alpha 2A gamma 2(53)(D4)Ala-->Asp.";
RL   Hemoglobin 9:525-529(1985).
RN   [19]
RP   VARIANT BONAIRE ARG-40.
RX   PubMed=6186637; DOI=10.3109/03630268209046453;
RA   Nakatsuji T., Headlee M., Lam H., Wilson J.B., Huisman T.H.J.;
RT   "Hb F-Bonaire-Ga or alpha 2 A gamma 2 39(C5) Gln replaced by Arg,
RT   characterized by high pressure liquid chromatographic and microsequencing
RT   procedures.";
RL   Hemoglobin 6:599-606(1982).
RN   [20]
RP   VARIANT CALLUNA ARG-13.
RX   PubMed=6199326; DOI=10.3109/03630268309027936;
RA   Nakatsuji T., Lam H., Huisman T.H.J.;
RT   "Hb F-Calluna or alpha 2 gamma 2(12 Thr replaced by Arg; 75Ile; 136Ala) in
RT   a Caucasian baby.";
RL   Hemoglobin 7:563-566(1983).
RN   [21]
RP   VARIANT COBB GLY-38.
RX   PubMed=2419280; DOI=10.3109/03630268508997043;
RA   Chen S.S., Webber B.B., Kutlar A., Wilson J.B., Huisman T.H.J.;
RT   "Hb F-Cobb or alpha(2)A gamma(2)37(C3)Trp-->Gly.";
RL   Hemoglobin 9:617-619(1985).
RN   [22]
RP   VARIANT DAMMAM ASN-80.
RX   PubMed=2411679; DOI=10.3109/03630268508996998;
RA   Al-Awamy B.H., Niazi G.A., Al-Mouzan M.I., Wilson J.B., Chen S.S.,
RA   Webber B.B., Huisman T.H.J.;
RT   "Hb F-Dammam or alpha 2A gamma 2(79) (EF3) Asp-->Asn.";
RL   Hemoglobin 9:171-173(1985).
RN   [23]
RP   VARIANT DICKINSON ARG-98.
RX   PubMed=4455303; DOI=10.1111/j.1365-2141.1974.tb06670.x;
RA   Schneider R.G., Haggard M.E., Gustavson L.P., Brimhall B., Jones R.T.;
RT   "Genetic haemoglobin abnormalities in about 9000 Black and 7000 White
RT   newborns; haemoglobin F Dickinson (Agamma97His-Arg), a new variant.";
RL   Br. J. Haematol. 28:515-524(1974).
RN   [24]
RP   VARIANT FUKUYAMA ASN-44.
RX   PubMed=2467893; DOI=10.3109/03630268908998058;
RA   Hidaka K., Iuchi I., Nakahara H., Iwakawa G.;
RT   "Hb F-Fukuyama or A gamma T43(CD2)Asp-->Asn.";
RL   Hemoglobin 13:93-96(1989).
RN   [25]
RP   VARIANT HULL LYS-122.
RX   PubMed=6038320; DOI=10.1136/bmj.3.5564.531;
RA   Sacker L.S., Beale D., Black A.J., Huntsman R.G., Lehmann H., Lorkin P.A.;
RT   "Haemoglobin F Hull (gamma-121 glutamic acid-->lysine), homologous with
RT   haemoglobins O Arab and O Indonesia.";
RL   BMJ 3:531-533(1967).
RN   [26]
RP   VARIANT IWATA ARG-73.
RX   PubMed=6163752; DOI=10.3109/03630268108996920;
RA   Fuyuno K., Torigoe T., Ohba Y., Matsuoka M., Miyaji T.;
RT   "Survey of cord blood hemoglobin in Japan and identification of two new
RT   gamma chain variants.";
RL   Hemoglobin 5:139-151(1981).
RN   [27]
RP   VARIANT IZUMI GLY-7.
RX   PubMed=6197997; DOI=10.1016/0167-4838(83)90231-5;
RA   Wada Y., Hayashi A., Masanori F., Katakuse I., Ichihara T., Nakabushi H.,
RA   Matsuo T., Sakurai T., Matsuda H.;
RT   "Characterization of a new fetal hemoglobin variant, Hb F Izumi A gamma
RT   6Glu replaced by Gly, by molecular secondary ion mass spectrometry.";
RL   Biochim. Biophys. Acta 749:244-248(1983).
RN   [28]
RP   VARIANT JAMAICA GLU-62.
RX   PubMed=5491586; DOI=10.1111/j.1365-2141.1970.tb01450.x;
RA   Ahern E.J., Jones R.T., Brimhall B., Gray R.H.;
RT   "Haemoglobin F Jamaica (alpha-2 gamma-2 61 Lys leads to Glu; 136 Ala).";
RL   Br. J. Haematol. 18:369-375(1970).
RN   [29]
RP   VARIANT JIANGSU MET-135.
RX   PubMed=1703137; DOI=10.3109/03630269009046959;
RA   Plaseska D., Kutlar F., Wilson J.B., Webber B.B., Zeng Y.-T.,
RA   Huisman T.H.J.;
RT   "Hb F-Jiangsu, the first gamma chain variant with a valine->methionine
RT   substitution: alpha 2A gamma 2 134(H12)Val->Met.";
RL   Hemoglobin 14:177-183(1990).
RN   [30]
RP   VARIANT KOTOBUKI GLY-7.
RX   PubMed=6175602; DOI=10.3109/03630268208996931;
RA   Yoshinaka H., Ohba Y., Hattori Y., Matsuoka M., Miyaji T., Fuyuno K.;
RT   "A new gamma chain variant, HB F Kotobuki or AI gamma 6 (A3) Glu leads to
RT   Gly.";
RL   Hemoglobin 6:37-42(1982).
RN   [31]
RP   VARIANT KUALA LUMPUR GLY-23.
RX   PubMed=4765089; DOI=10.1016/0005-2795(73)90297-3;
RA   Lie-Injo L.E., Wiltshire B.B., Lehmann H.;
RT   "Structural identification of haemoglobin F Kuala Lumpur: alpha2 gamma2
RT   22(B4)Asp leads to Gly; 136 Ala.";
RL   Biochim. Biophys. Acta 322:224-230(1973).
RN   [32]
RP   VARIANT MACEDONIA-I GLN-3.
RX   PubMed=7928382; DOI=10.3109/03630269409043626;
RA   Plaseska D., Cepreganova-Krstik B., Momirovska A., Efremov G.D.;
RT   "Hb F-Macedonia-I or alpha 2A gamma (2)2(NA2)His-->Gln.";
RL   Hemoglobin 18:241-245(1994).
RN   [33]
RP   VARIANT PENDERGRASS ARG-37.
RX   PubMed=2581920; DOI=10.3109/03630268508996985;
RA   Chen S.S., Wilson J.B., Huisman T.H.J.;
RT   "Hb F-Pendergrass, an A gamma I variant with a Pro-->Arg substitution at
RT   position gamma 36(C2).";
RL   Hemoglobin 9:73-77(1985).
RN   [34]
RP   VARIANT PORDENONE GLN-7.
RX   PubMed=6183236; DOI=10.3109/03630268208996945;
RA   Nakatsuji T., Webber B., Lam H., Wilson J.B., Huisman T.H.J.,
RA   Sciarratta G.V., Sansone G., Molaro G.L.;
RT   "A new gamma chain variant: Hb F-Pordenone [gamma 6(A3) Glu replaced by
RT   Gln: 75ILE: 136ALA].";
RL   Hemoglobin 6:397-401(1982).
RN   [35]
RP   VARIANT SARDINIA THR-76.
RX   PubMed=808940; DOI=10.1159/000208204;
RA   Grifone V., Kamuzora H., Lehmann H., Charlesworth D.;
RT   "A new Hb variant: Hb F Sardinia gamma75(E19) isoleucine leads to threonine
RT   found in a family with Hb G Philadelphia, beta-chain deficiency and a
RT   Lepore-like haemoglobin indistinguishable from Hb A2.";
RL   Acta Haematol. 53:347-355(1975).
RN   [36]
RP   VARIANT SIENA LYS-122.
RX   PubMed=6188719; DOI=10.3109/03630268309038403;
RA   Care A., Marinucci M., Massa A., Maffi D., Sposi N.M., Improta T.,
RA   Tentori L.;
RT   "Hb F-Siena (alpha 2 a gamma t2 121 (GH4) Glu leads to Lys). A new fetal
RT   hemoglobin variant.";
RL   Hemoglobin 7:79-83(1983).
RN   [37]
RP   VARIANT TEXAS-1 LYS-6.
RX   PubMed=6019034; DOI=10.1111/j.1365-2141.1967.tb08737.x;
RA   Jenkins G.C., Beale D., Black A.J., Huntsman R.G., Lehmann H.;
RT   "Haemoglobin F Texas I(alpha-2,gamma-2-5glu-lys): a variant of haemoglobin
RT   F.";
RL   Br. J. Haematol. 13:252-255(1967).
RN   [38]
RP   VARIANT VICTORIA JUBILEE TYR-81.
RX   PubMed=1138921; DOI=10.1016/0005-2795(75)90230-5;
RA   Ahern E., Holder W., Ahern V., Serjeant G.R., Serjeant B., Forbes M.,
RA   Brimhall B., Jones R.T.;
RT   "Haemoglobin F Victoria Jubilee (alpha 2 A gamma 2 80 Asp-Try).";
RL   Biochim. Biophys. Acta 393:188-194(1975).
RN   [39]
RP   VARIANT WOODSTOCK LYS-41.
RX   PubMed=1802881; DOI=10.3109/03630269108998857;
RA   Huisman T.H.J., Kutlar F., Gu L.H.;
RT   "Gamma chain abnormalities and gamma-globin gene rearrangements in newborn
RT   babies of various populations.";
RL   Hemoglobin 15:349-379(1991).
RN   [40]
RP   VARIANT XIN-SU HIS-74.
RX   PubMed=2448269; DOI=10.3109/03630268708998007;
RA   Ma M., Hu H., Kutlar F., Wilson J.B., Huisman T.H.J.;
RT   "Hb F-Xin-Su or A gamma I73(E17)Asp-->His: a new slow-moving fetal
RT   hemoglobin variant.";
RL   Hemoglobin 11:473-479(1987).
RN   [41]
RP   VARIANT XINJIANG ARG-26.
RX   PubMed=2448268; DOI=10.3109/03630268708998006;
RA   Hu H., Ma M.;
RT   "Hb F-Xinjiang or A gamma T25(B7)Gly-->Arg: a new slow-moving unstable
RT   fetal hemoglobin variant.";
RL   Hemoglobin 11:465-472(1987).
RN   [42]
RP   VARIANT YAMAGUCHI ASN-81.
RX   PubMed=6198905; DOI=10.1002/ajh.2830160212;
RA   Nakatsuji T., Ohba Y., Huisman T.H.J.;
RT   "HB F-Yamaguchi (gamma 75Thr, gamma 80Asn, gamma 136Ala) is associated with
RT   G gamma-thalassemia.";
RL   Am. J. Hematol. 16:189-192(1984).
CC   -!- FUNCTION: Gamma chains make up the fetal hemoglobin F, in combination
CC       with alpha chains.
CC   -!- SUBUNIT: Heterotetramer of two alpha chains and two gamma chains in
CC       fetal hemoglobin (Hb F). In the case of deletions affecting one or more
CC       of the alpha chains, the excess gamma chains form homotetramers that
CC       exhibit neither Bohr effect nor heme-heme cooperativity (hemoglobin
CC       Bart's). {ECO:0000269|PubMed:11514664, ECO:0000269|PubMed:20925047,
CC       ECO:0000269|PubMed:21747884, ECO:0000269|PubMed:22096240}.
CC   -!- TISSUE SPECIFICITY: Red blood cells.
CC   -!- DEVELOPMENTAL STAGE: Expressed until four or five weeks after birth.
CC       Detected at very low levels in adults, where it constitutes about 1% of
CC       the total hemoglobin. In contrast, the levels of fetal hemoglobin F
CC       (two alpha chains and two gamma chains) are increased in children and
CC       adults with beta-thalassemia or sickle-cell disease. In cases of
CC       homozygous alpha-thalassemia, homotetrameric hemoglobin Bart's is
CC       highly expressed and is the predominant form of hemoglobin after 10
CC       weeks of gestation. Its levels increase steadily after 10 weeks of
CC       gestation and until birth (at protein level).
CC       {ECO:0000269|PubMed:20925047, ECO:0000269|PubMed:21747884,
CC       ECO:0000269|PubMed:22096240}.
CC   -!- INDUCTION: By 5-azacytidine. {ECO:0000269|PubMed:16131492}.
CC   -!- PTM: Acetylation of Gly-2 converts Hb F to the minor Hb F1.
CC       {ECO:0000269|PubMed:5554303}.
CC   -!- SIMILARITY: Belongs to the globin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00238}.
CC   -!- CAUTION: The modification form of Leu-142 is subject of controversy and
CC       could be the artifactual result of sample handling.
CC       {ECO:0000305|PubMed:7690768}.
CC   -!- WEB RESOURCE: Name=HbVar; Note=Human hemoglobin variants and
CC       thalassemias;
CC       URL="http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=directlink&gene=HBG1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M91036; AAB59429.1; -; Genomic_DNA.
DR   EMBL; M91037; AAA58493.1; -; Genomic_DNA.
DR   EMBL; V00513; CAA23771.1; -; Genomic_DNA.
DR   EMBL; V00514; CAA23772.1; -; Genomic_DNA.
DR   EMBL; J00176; AAA52637.1; -; Genomic_DNA.
DR   EMBL; U01317; AAA16332.1; -; Genomic_DNA.
DR   EMBL; AF130098; AAG35523.1; -; mRNA.
DR   EMBL; CH471064; EAW68804.1; -; Genomic_DNA.
DR   EMBL; BC010913; AAH10913.1; -; mRNA.
DR   EMBL; BC020719; AAH20719.1; -; mRNA.
DR   EMBL; AF487523; AAL99545.1; -; Genomic_DNA.
DR   CCDS; CCDS7754.1; -.
DR   PIR; A90803; HGHUA.
DR   RefSeq; NP_000550.2; NM_000559.2.
DR   PDB; 1I3D; X-ray; 1.70 A; A/B=2-147.
DR   PDB; 1I3E; X-ray; 1.86 A; A/B=2-147.
DR   PDBsum; 1I3D; -.
DR   PDBsum; 1I3E; -.
DR   SMR; P69891; -.
DR   BioGRID; 109297; 13.
DR   ComplexPortal; CPX-2930; Hemoglobin Portland-1 Variant 1 complex.
DR   ComplexPortal; CPX-2932; Hemoglobin HbF Variant 1 complex.
DR   ComplexPortal; CPX-2934; Hemoglobin Bart's complex.
DR   IntAct; P69891; 3.
DR   iPTMnet; P69891; -.
DR   PhosphoSitePlus; P69891; -.
DR   BioMuta; HBG1; -.
DR   DMDM; 56749860; -.
DR   jPOST; P69891; -.
DR   MassIVE; P69891; -.
DR   MaxQB; P69891; -.
DR   PeptideAtlas; P69891; -.
DR   PRIDE; P69891; -.
DR   ProteomicsDB; 57545; -.
DR   ABCD; P69891; 1 sequenced antibody.
DR   Antibodypedia; 23583; 155 antibodies.
DR   DNASU; 3047; -.
DR   Ensembl; ENST00000330597; ENSP00000327431; ENSG00000213934.
DR   GeneID; 3047; -.
DR   KEGG; hsa:3047; -.
DR   UCSC; uc001mah.2; human.
DR   CTD; 3047; -.
DR   DisGeNET; 3047; -.
DR   GeneCards; HBG1; -.
DR   HGNC; HGNC:4831; HBG1.
DR   HPA; ENSG00000213934; Tissue enriched (placenta).
DR   MalaCards; HBG1; -.
DR   MIM; 142200; gene.
DR   neXtProt; NX_P69891; -.
DR   Orphanet; 231237; Delta-beta-thalassemia.
DR   Orphanet; 46532; Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome.
DR   Orphanet; 251380; Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome.
DR   PharmGKB; PA29206; -.
DR   VEuPathDB; HostDB:ENSG00000213934.6; -.
DR   GeneTree; ENSGT00940000162659; -.
DR   HOGENOM; CLU_003827_10_0_1; -.
DR   InParanoid; P69891; -.
DR   OMA; WQKFLSA; -.
DR   OrthoDB; 1370439at2759; -.
DR   PhylomeDB; P69891; -.
DR   TreeFam; TF333268; -.
DR   PathwayCommons; P69891; -.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; P69891; -.
DR   BioGRID-ORCS; 3047; 6 hits in 913 CRISPR screens.
DR   ChiTaRS; HBG1; human.
DR   EvolutionaryTrace; P69891; -.
DR   GenomeRNAi; 3047; -.
DR   Pharos; P69891; Tbio.
DR   PRO; PR:P69891; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P69891; protein.
DR   Bgee; ENSG00000213934; Expressed in adrenal tissue and 89 other tissues.
DR   ExpressionAtlas; P69891; baseline and differential.
DR   Genevisible; P69891; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031838; C:haptoglobin-hemoglobin complex; IBA:GO_Central.
DR   GO; GO:0005833; C:hemoglobin complex; IBA:GO_Central.
DR   GO; GO:0020037; F:heme binding; IBA:GO_Central.
DR   GO; GO:0031721; F:hemoglobin alpha binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043177; F:organic acid binding; IBA:GO_Central.
DR   GO; GO:0019825; F:oxygen binding; IBA:GO_Central.
DR   GO; GO:0005344; F:oxygen carrier activity; IBA:GO_Central.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0098869; P:cellular oxidant detoxification; IEA:GOC.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IBA:GO_Central.
DR   CDD; cd08925; Hb-beta-like; 1.
DR   Gene3D; 1.10.490.10; -; 1.
DR   InterPro; IPR000971; Globin.
DR   InterPro; IPR009050; Globin-like_sf.
DR   InterPro; IPR012292; Globin/Proto.
DR   InterPro; IPR002337; Haemoglobin_b.
DR   Pfam; PF00042; Globin; 1.
DR   PRINTS; PR00814; BETAHAEM.
DR   SUPFAM; SSF46458; SSF46458; 1.
DR   PROSITE; PS01033; GLOBIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Disease variant;
KW   Heme; Iron; Metal-binding; Oxygen transport; Phosphoprotein;
KW   Reference proteome; S-nitrosylation; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P61920"
FT   CHAIN           2..147
FT                   /note="Hemoglobin subunit gamma-1"
FT                   /id="PRO_0000053253"
FT   METAL           64
FT                   /note="Iron (heme distal ligand)"
FT                   /evidence="ECO:0000250|UniProtKB:P80044"
FT   METAL           93
FT                   /note="Iron (heme proximal ligand)"
FT                   /evidence="ECO:0000269|PubMed:11514664,
FT                   ECO:0007744|PDB:1I3D, ECO:0007744|PDB:1I3E"
FT   MOD_RES         2
FT                   /note="N-acetylglycine; in form Hb F1"
FT                   /evidence="ECO:0000269|PubMed:5554303"
FT   MOD_RES         13
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P68871"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         53
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         60
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68871"
FT   MOD_RES         83
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68871"
FT   MOD_RES         94
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P68871"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         3
FT                   /note="H -> Q (in Macedonia-I; dbSNP:rs35315638)"
FT                   /evidence="ECO:0000269|PubMed:7928382"
FT                   /id="VAR_003124"
FT   VARIANT         6
FT                   /note="E -> K (in Texas-1; dbSNP:rs34427034)"
FT                   /evidence="ECO:0000269|PubMed:6019034"
FT                   /id="VAR_003125"
FT   VARIANT         7
FT                   /note="E -> G (in Izumi/Kotobuki; dbSNP:rs34432567)"
FT                   /evidence="ECO:0000269|PubMed:6175602,
FT                   ECO:0000269|PubMed:6197997"
FT                   /id="VAR_003127"
FT   VARIANT         7
FT                   /note="E -> Q (in Pordenone; dbSNP:rs33924825)"
FT                   /evidence="ECO:0000269|PubMed:6183236"
FT                   /id="VAR_003128"
FT   VARIANT         13
FT                   /note="T -> R (in Calluna; dbSNP:rs33992775)"
FT                   /evidence="ECO:0000269|PubMed:6199326"
FT                   /id="VAR_003130"
FT   VARIANT         23
FT                   /note="D -> G (in Kuala Lumpur; dbSNP:rs33970907)"
FT                   /evidence="ECO:0000269|PubMed:4765089"
FT                   /id="VAR_003135"
FT   VARIANT         26
FT                   /note="G -> R (in Xinjiang; unstable; dbSNP:rs35957832)"
FT                   /evidence="ECO:0000269|PubMed:2448268"
FT                   /id="VAR_003138"
FT   VARIANT         37
FT                   /note="P -> R (in Pendergrass; dbSNP:rs41404150)"
FT                   /evidence="ECO:0000269|PubMed:2581920"
FT                   /id="VAR_003141"
FT   VARIANT         38
FT                   /note="W -> G (in Cobb; dbSNP:rs35700518)"
FT                   /evidence="ECO:0000269|PubMed:2419280"
FT                   /id="VAR_003142"
FT   VARIANT         40
FT                   /note="Q -> R (in Bonaire; dbSNP:rs35977759)"
FT                   /evidence="ECO:0000269|PubMed:6186637"
FT                   /id="VAR_003143"
FT   VARIANT         41
FT                   /note="R -> K (in Woodstock; dbSNP:rs33974602)"
FT                   /evidence="ECO:0000269|PubMed:1802881"
FT                   /id="VAR_003145"
FT   VARIANT         44
FT                   /note="D -> N (in Fukuyama; dbSNP:rs41475844)"
FT                   /evidence="ECO:0000269|PubMed:2467893"
FT                   /id="VAR_003147"
FT   VARIANT         54
FT                   /note="A -> D (in Beech island; dbSNP:rs35746147)"
FT                   /evidence="ECO:0000269|PubMed:2417989"
FT                   /id="VAR_003149"
FT   VARIANT         62
FT                   /note="K -> E (in Jamaica; dbSNP:rs34747494)"
FT                   /evidence="ECO:0000269|PubMed:5491586"
FT                   /id="VAR_003153"
FT   VARIANT         73
FT                   /note="G -> R (in Iwata; dbSNP:rs34049890)"
FT                   /evidence="ECO:0000269|PubMed:6163752"
FT                   /id="VAR_003158"
FT   VARIANT         74
FT                   /note="D -> H (in Xin-su; dbSNP:rs33965337)"
FT                   /evidence="ECO:0000269|PubMed:2448269"
FT                   /id="VAR_003160"
FT   VARIANT         74
FT                   /note="D -> N (in Forest Park; associated with T-76;
FT                   dbSNP:rs33965337)"
FT                   /id="VAR_003159"
FT   VARIANT         76
FT                   /note="I -> T (in Sardinia/Forest Park; associated with N-
FT                   74; dbSNP:rs1061234)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:808940"
FT                   /id="VAR_003161"
FT   VARIANT         80
FT                   /note="D -> N (in Dammam; dbSNP:rs34435255)"
FT                   /evidence="ECO:0000269|PubMed:2411679"
FT                   /id="VAR_003163"
FT   VARIANT         81
FT                   /note="D -> N (in Yamaguchi; dbSNP:rs33947112)"
FT                   /evidence="ECO:0000269|PubMed:6198905"
FT                   /id="VAR_003165"
FT   VARIANT         81
FT                   /note="D -> Y (in Victoria jubilee; dbSNP:rs33947112)"
FT                   /evidence="ECO:0000269|PubMed:1138921"
FT                   /id="VAR_003164"
FT   VARIANT         98
FT                   /note="H -> R (in Dickinson; dbSNP:rs34127117)"
FT                   /evidence="ECO:0000269|PubMed:4455303"
FT                   /id="VAR_003168"
FT   VARIANT         122
FT                   /note="E -> K (in Siena/Hull; dbSNP:rs33963857)"
FT                   /evidence="ECO:0000269|PubMed:6038320,
FT                   ECO:0000269|PubMed:6188719"
FT                   /id="VAR_003173"
FT   VARIANT         129
FT                   /note="A -> T (in Baskent; dbSNP:rs41330850)"
FT                   /evidence="ECO:0000269|PubMed:2454900"
FT                   /id="VAR_003175"
FT   VARIANT         135
FT                   /note="V -> M (in Jiangsu; dbSNP:rs35849660)"
FT                   /evidence="ECO:0000269|PubMed:1703137"
FT                   /id="VAR_003177"
FT   HELIX           6..17
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           21..35
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           37..46
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           52..57
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           59..75
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           76..81
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           82..85
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           87..94
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   TURN            95..97
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           101..119
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           120..122
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           125..142
FT                   /evidence="ECO:0007744|PDB:1I3D"
FT   HELIX           144..146
FT                   /evidence="ECO:0007744|PDB:1I3D"
SQ   SEQUENCE   147 AA;  16140 MW;  8FCDC3DA1B416DDE CRC64;
     MGHFTEEDKA TITSLWGKVN VEDAGGETLG RLLVVYPWTQ RFFDSFGNLS SASAIMGNPK
     VKAHGKKVLT SLGDAIKHLD DLKGTFAQLS ELHCDKLHVD PENFKLLGNV LVTVLAIHFG
     KEFTPEVQAS WQKMVTAVAS ALSSRYH
//
